MX2018000126A - Metodos para la administracion linfatica de agentes activos. - Google Patents

Metodos para la administracion linfatica de agentes activos.

Info

Publication number
MX2018000126A
MX2018000126A MX2018000126A MX2018000126A MX2018000126A MX 2018000126 A MX2018000126 A MX 2018000126A MX 2018000126 A MX2018000126 A MX 2018000126A MX 2018000126 A MX2018000126 A MX 2018000126A MX 2018000126 A MX2018000126 A MX 2018000126A
Authority
MX
Mexico
Prior art keywords
methods
active agents
lymphatic delivery
agents
delivery
Prior art date
Application number
MX2018000126A
Other languages
English (en)
Inventor
Frederick Ross Russell
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of MX2018000126A publication Critical patent/MX2018000126A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Abstract

La presente invención se refiere a la administración de agentes a la piel. Los métodos para administrar agentes tales como agentes bioactivos se contemplan en la presente invención. Específicamente, se describen métodos para administrar un agente a una o más áreas de la epidermis y, de esta manera, al sistema linfático.
MX2018000126A 2015-07-24 2016-07-22 Metodos para la administracion linfatica de agentes activos. MX2018000126A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562196568P 2015-07-24 2015-07-24
US201562196558P 2015-07-24 2015-07-24
PCT/US2016/043656 WO2017019535A2 (en) 2015-07-24 2016-07-22 Methods for lymphatic delivery of active agents

Publications (1)

Publication Number Publication Date
MX2018000126A true MX2018000126A (es) 2018-03-23

Family

ID=57885089

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000126A MX2018000126A (es) 2015-07-24 2016-07-22 Metodos para la administracion linfatica de agentes activos.
MX2022014634A MX2022014634A (es) 2015-07-24 2018-01-08 Metodos para la administracion linfatica de agentes activos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022014634A MX2022014634A (es) 2015-07-24 2018-01-08 Metodos para la administracion linfatica de agentes activos.

Country Status (15)

Country Link
US (2) US10737082B2 (es)
EP (2) EP3922238A1 (es)
JP (3) JP6929829B2 (es)
KR (1) KR20180035210A (es)
CN (1) CN107949418A (es)
AU (3) AU2016297832B2 (es)
BR (1) BR112018001435A2 (es)
CA (1) CA2991459A1 (es)
DK (1) DK3325081T3 (es)
ES (1) ES2893673T3 (es)
HU (1) HUE056424T2 (es)
MX (2) MX2018000126A (es)
PL (1) PL3325081T3 (es)
RU (1) RU2719946C2 (es)
WO (1) WO2017019535A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3325080B1 (en) * 2015-07-24 2021-09-01 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
JP6929829B2 (ja) * 2015-07-24 2021-09-01 ソレント・セラピューティクス・インコーポレイテッド 薬剤送達装置
JP7182794B2 (ja) * 2017-08-31 2022-12-05 国立大学法人東北大学 リンパ行性薬剤送達法に有効な薬剤を含む溶液の適正な浸透圧域
US20230001170A1 (en) 2019-12-05 2023-01-05 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic devliery device
CA3205976A1 (en) 2021-01-22 2022-07-28 Russell F. Ross Device for microliter-scale lymphatic delivery of coronavirus vaccines
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CN117916264A (zh) 2021-06-09 2024-04-19 索伦托药业有限公司 通过经由淋巴微针递送装置施用抗pd-1或抗pd-l1治疗剂来治疗癌症的方法
CN113368385A (zh) * 2021-06-21 2021-09-10 温州医科大学慈溪生物医药研究院 利用淋巴通路递送生物大分子药物入脑的输送系统
WO2023023074A1 (en) 2021-08-18 2023-02-23 Sorrento Therapeutics, Inc. Therapeutic agents targeting the lymphatic system

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US20020095134A1 (en) 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
CA2380769A1 (en) * 2000-06-01 2001-12-06 Watson Pharmaceuticals, Inc. Transdermal delivery of lasofoxifene
JP4383168B2 (ja) * 2001-09-12 2009-12-16 ベクトン・ディキンソン・アンド・カンパニー マイクロ針投与デバイスおよび薬物投与デバイス
WO2004064889A2 (en) 2003-01-16 2004-08-05 Becton, Dickinson And Company Intradermal cellular delivery using narrow gauge micro-cannula
AU2004264839B2 (en) * 2003-06-13 2009-06-04 Becton, Dickinson And Company Improved intra-dermal delivery of biologically active agents
WO2005023328A2 (en) 2003-08-26 2005-03-17 Becton Dickinson And Company Methods for intradermal delivery of therapeutics agents
WO2006127962A2 (en) 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
CA2618807C (en) 2005-08-12 2015-01-06 University Health Network Methods and devices for lymphatic targeting
WO2007047539A2 (en) 2005-10-14 2007-04-26 Medtronic, Inc. Localized delivery to the lymphatic system
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
WO2008038140A2 (en) 2006-06-07 2008-04-03 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8798932B2 (en) * 2008-10-31 2014-08-05 The Invention Science Fund I, Llc Frozen compositions and methods for piercing a substrate
CA2796965C (en) * 2010-04-28 2019-04-16 Kimberly-Clark Worldwide, Inc. Method for increasing permeability of an epithelial barrier
MX345837B (es) 2010-04-28 2017-02-16 Kimberly-Clark Worldwide Incorporated Dispositivo para la entrega de un medicamento para la artritis reumatoide.
AU2011246882B2 (en) 2010-04-28 2016-02-25 Sorrento Therapeutics, Inc. Nanopatterned medical device with enhanced cellular interaction
MX336139B (es) 2010-04-28 2016-01-08 Kimberly Clark Co Dispositivos medicos para la entrega de arn de interferencia corta.
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
BR112014009346B1 (pt) * 2011-10-17 2020-09-15 Massachusetts Institute Of Technology Entrega intracelular
EP3574950B1 (en) * 2011-10-27 2021-02-17 Sorrento Therapeutics, Inc. Transdermal delivery of high viscosity bioactive agents
US20170246439A9 (en) 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
CA2871770C (en) * 2012-05-01 2020-07-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Tip-loaded microneedle arrays for transdermal insertion
US9861801B2 (en) 2013-02-28 2018-01-09 Kimberly-Clark Worldwide, Inc. Drug delivery device
EP2961471B1 (en) 2013-02-28 2023-10-25 Sorrento Therapeutics, Inc. Transdermal drug delivery device
US9795775B2 (en) 2013-05-23 2017-10-24 Kimberly-Clark Worldwide, Inc. Microneedles with improved open channel cross-sectional geometries
EP3325080B1 (en) * 2015-07-24 2021-09-01 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
JP6929829B2 (ja) * 2015-07-24 2021-09-01 ソレント・セラピューティクス・インコーポレイテッド 薬剤送達装置

Also Published As

Publication number Publication date
PL3325081T3 (pl) 2021-12-20
BR112018001435A2 (pt) 2018-09-11
ES2893673T3 (es) 2022-02-09
AU2022275393A1 (en) 2023-01-05
AU2020233748B2 (en) 2022-08-25
KR20180035210A (ko) 2018-04-05
AU2016297832B2 (en) 2020-07-16
WO2017019535A2 (en) 2017-02-02
JP2021185160A (ja) 2021-12-09
EP3922238A1 (en) 2021-12-15
EP3325081A4 (en) 2019-04-10
DK3325081T3 (da) 2021-10-11
HUE056424T2 (hu) 2022-02-28
RU2018104104A (ru) 2019-08-26
US10737082B2 (en) 2020-08-11
AU2020233748A1 (en) 2020-10-08
US20200338329A1 (en) 2020-10-29
CN107949418A (zh) 2018-04-20
US20180193625A1 (en) 2018-07-12
JP6929829B2 (ja) 2021-09-01
AU2016297832A1 (en) 2018-02-15
JP2023015135A (ja) 2023-01-31
RU2018104104A3 (es) 2019-10-31
EP3325081A2 (en) 2018-05-30
CA2991459A1 (en) 2017-02-02
MX2022014634A (es) 2023-01-18
RU2719946C2 (ru) 2020-04-23
EP3325081B1 (en) 2021-09-08
JP7167272B2 (ja) 2022-11-08
JP2018522002A (ja) 2018-08-09

Similar Documents

Publication Publication Date Title
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
MX2022014277A (es) Metodos para una mejor administracion de agentes activos a tumores.
PH12017500070A1 (en) Methods of treating cancer using tigit inhibitors and anti-cancer agents
WO2017134302A3 (en) Targeted therapeutic agents and uses thereof
MX2018012486A (es) Composiciones para aplicacion topica de compuestos.
MX2018008190A (es) Sistemas y metodos para la administracion transdermica a largo plazo.
PH12016500871A1 (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
GB2541571A (en) Pharmaceutical compositions
MY195009A (en) Cellular Targeted Active Ingredient Delivery System
MX2021000773A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos de uso del mismo.
PH12016501527B1 (en) Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
MX2016007445A (es) Inhibidores de f1f0-atpasa de trifluorometil pirazolil guanidina y usos terapeuticos de los mismos.
MX2018005796A (es) Reduccion de la sensacion de picazon en la piel.
BR112018000217A2 (pt) sistemas de distribuição de nanopartículas aperfeiçoados
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
MX2018005035A (es) Formulaciones de liberacion sostenida de anestesicos locales.
MX2022011564A (es) Tratamiento del dolor.
MX2017009608A (es) Compuestos anticancerigenos.
MX2016005614A (es) Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
NZ746011A (en) Glycoalkaloid combinations and various uses thereof
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MX2017013879A (es) Composiciones que comprenden anakinra.
SG10201902499VA (en) Therapeutic nanoparticles and related compositions, methods and systems
MX2017003949A (es) Derivados peptidicos novedosos y sus usos.
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis